标题
Reversible lysine-targeted probes reveal residence time-based kinase selectivity
作者
关键词
-
出版物
Nature Chemical Biology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-20
DOI
10.1038/s41589-022-01019-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Strategic Design of Catalytic Lysine‐Targeting Reversible Covalent BCR‐ABL Inhibitors
- (2021) David Quach et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pathogenic MAST3 Variants in the STK Domain Are Associated with Epilepsy
- (2021) Egidio Spinelli et al. ANNALS OF NEUROLOGY
- Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
- (2021) Kevin Freeman-Cook et al. CANCER CELL
- Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
- (2021) Kevin D. Freeman-Cook et al. JOURNAL OF MEDICINAL CHEMISTRY
- Full-featured, real-time database searching platform enables fast and accurate multiplexed quantitative proteomics.
- (2020) Devin K. Schweppe et al. JOURNAL OF PROTEOME RESEARCH
- Discovery of Lysine-Targeted eIF4E Inhibitors through Covalent Docking
- (2020) Xiaobo Wan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Ligand Conformational Bias Drives Enantioselective Modification of a Surface-Exposed Lysine on Hsp90
- (2020) Adolfo Cuesta et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients
- (2020) Christian Gampe et al. JOURNAL OF MEDICINAL CHEMISTRY
- KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
- (2020) David S. Hong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
- (2019) Luca Gambini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lysine-Targeted Inhibitors and Chemoproteomic Probes
- (2019) Adolfo Cuesta et al. Annual Review of Biochemistry
- Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
- (2019) Brian A. Lanman et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Cysteinome of Protein Kinases as a Target in Drug Development
- (2018) Apirat Chaikuad et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition
- (2018) Samuel E. Dalton et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer
- (2018) Hayley J. Donnella et al. Nature Chemical Biology
- Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide
- (2018) Tomonori Tamura et al. Nature Communications
- The functional diversity of Aurora kinases: a comprehensive review
- (2018) Estelle Willems et al. Cell Division
- Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes
- (2017) Qian Zhao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Global profiling of lysine reactivity and ligandability in the human proteome
- (2017) Stephan M. Hacker et al. Nature Chemistry
- Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition
- (2017) Veronica Musante et al. eLife
- GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease
- (2016) Donna Oksenberg et al. BRITISH JOURNAL OF HAEMATOLOGY
- The hVps34‐SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth
- (2016) Ruzica Bago et al. EMBO JOURNAL
- Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors
- (2016) Mark W. Richards et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prolonged and tunable residence time using reversible covalent kinase inhibitors
- (2015) J Michael Bradshaw et al. Nature Chemical Biology
- The drug–target residence time model: a 10-year retrospective
- (2015) Robert A. Copeland NATURE REVIEWS DRUG DISCOVERY
- AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
- (2015) Pasi A. Jänne et al. NEW ENGLAND JOURNAL OF MEDICINE
- The structure of C290A:C393A Aurora A provides structural insights into kinase regulation
- (2015) Selena G. Burgess et al. Acta Crystallographica Section F-Structural Biology Communications
- Drugging MYCN through an Allosteric Transition in Aurora Kinase A
- (2014) William Clay Gustafson et al. CANCER CELL
- Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor
- (2014) M. Raymond V. Finlay et al. JOURNAL OF MEDICINAL CHEMISTRY
- SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
- (2014) Jessica A. Gasser et al. MOLECULAR CELL
- Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
- (2013) Qingsong Liu et al. CHEMISTRY & BIOLOGY
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- JLigand: a graphical tool for theCCP4 template-restraint library
- (2012) Andrey A. Lebedev et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Towards automated crystallographic structure refinement withphenix.refine
- (2012) Pavel V. Afonine et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Selective Targeting of Distinct Active Site Nucleophiles by Irreversible Src-Family Kinase Inhibitors
- (2012) Nathan N. Gushwa et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The resurgence of covalent drugs
- (2011) Juswinder Singh et al. NATURE REVIEWS DRUG DISCOVERY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
- (2010) L. A. Honigberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- (2009) Krishna M. Vasudevan et al. CANCER CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started